Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage

Apatinib, a novel and selective inhibitor of vascular endothelial growth factor (VEGF) receptor 2, has been demonstrated recently to exhibit anticancer efficacy by inhibiting the VEGF signaling pathway. Given the importance of VEGF in retinal vascular leakage, the present study was designed to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Ji Hoon, Nguyen, Hong Khanh, Lee, Jung Eun, Suh, Wonhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940015/
https://www.ncbi.nlm.nih.gov/pubmed/27462154
http://dx.doi.org/10.2147/IJN.S108452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940015/
https://www.ncbi.nlm.nih.gov/pubmed/27462154
http://dx.doi.org/10.2147/IJN.S108452

Ejemplares similares